Alibaba Health Information Technology Limited (0241.HK)
- Previous Close
2.650 - Open
2.610 - Bid 2.610 x --
- Ask 2.620 x --
- Day's Range
2.590 - 2.660 - 52 Week Range
2.590 - 5.850 - Volume
35,695,218 - Avg. Volume
39,320,807 - Market Cap (intraday)
41.999B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
37.29 - EPS (TTM)
0.070 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.57
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, adult and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and traditional Chinese medicine through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
www.alihealth.cn1,547
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 0241.HK
Performance Overview: 0241.HK
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0241.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0241.HK
Valuation Measures
Market Cap
42.00B
Enterprise Value
29.00B
Trailing P/E
40.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
2.41
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
31.65
Financial Highlights
Profitability and Income Statement
Profit Margin
2.90%
Return on Assets (ttm)
0.74%
Return on Equity (ttm)
5.27%
Revenue (ttm)
28.22B
Net Income Avi to Common (ttm)
817.1M
Diluted EPS (ttm)
0.070
Balance Sheet and Cash Flow
Total Cash (mrq)
12.11B
Total Debt/Equity (mrq)
0.55%
Levered Free Cash Flow (ttm)
218.64M
Research Analysis: 0241.HK
Analyst Price Targets
Fair Value
No Fair Value available for this ticker